Nutex Health, Inc. (NASDAQ: NUTX) Stock Competitors & Peer Comparison
See NUTX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NUTX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUTX | $145.87 | -5.01% | 868.6M | 11.27 | $12.94 | N/A |
| HCA | $382.19 | +1.51% | 84.8B | 13.20 | $28.96 | +0.78% |
| THC | $233.20 | +17.17% | 20.1B | 13.53 | $17.24 | N/A |
| DVA | $235.44 | +0.50% | 15.1B | 20.06 | $11.73 | N/A |
| SOLV | $78.01 | +1.00% | 13.5B | 12.50 | $6.24 | N/A |
| FMS | $24.59 | +0.61% | 13.2B | 9.76 | $2.52 | +3.52% |
| EHC | $112.89 | +1.65% | 11.2B | 19.83 | $5.69 | +0.67% |
| ENSG | $172.99 | +3.27% | 10.1B | 25.07 | $6.90 | +0.15% |
| UHS | $155.75 | +2.96% | 9.8B | 6.91 | $22.54 | +0.51% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
NUTX vs HCA Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, HCA has a market cap of 84.8B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while HCA trades at $382.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas HCA's P/E ratio is 13.20. In terms of profitability, NUTX's ROE is +0.31%, compared to HCA's ROE of -1.54%. Regarding short-term risk, NUTX is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
NUTX vs THC Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, THC has a market cap of 20.1B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while THC trades at $233.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas THC's P/E ratio is 13.53. In terms of profitability, NUTX's ROE is +0.31%, compared to THC's ROE of +0.38%. Regarding short-term risk, NUTX is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check THC's competition here
DaVita Inc. (NYSE: DVA)
NUTX vs DVA Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, DVA has a market cap of 15.1B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while DVA trades at $235.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas DVA's P/E ratio is 20.06. In terms of profitability, NUTX's ROE is +0.31%, compared to DVA's ROE of -1.33%. Regarding short-term risk, NUTX is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check DVA's competition here
Solventum Corporation (NYSE: SOLV)
NUTX vs SOLV Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, SOLV has a market cap of 13.5B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while SOLV trades at $78.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas SOLV's P/E ratio is 12.50. In terms of profitability, NUTX's ROE is +0.31%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, NUTX is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SOLV's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
NUTX vs FMS Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, FMS has a market cap of 13.2B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while FMS trades at $24.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas FMS's P/E ratio is 9.76. In terms of profitability, NUTX's ROE is +0.31%, compared to FMS's ROE of +0.07%. Regarding short-term risk, NUTX is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
NUTX vs EHC Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, EHC has a market cap of 11.2B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while EHC trades at $112.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas EHC's P/E ratio is 19.83. In terms of profitability, NUTX's ROE is +0.31%, compared to EHC's ROE of +0.25%. Regarding short-term risk, NUTX is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check EHC's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
NUTX vs ENSG Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, ENSG has a market cap of 10.1B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while ENSG trades at $172.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas ENSG's P/E ratio is 25.07. In terms of profitability, NUTX's ROE is +0.31%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, NUTX is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
NUTX vs UHS Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, UHS has a market cap of 9.8B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while UHS trades at $155.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas UHS's P/E ratio is 6.91. In terms of profitability, NUTX's ROE is +0.31%, compared to UHS's ROE of +0.21%. Regarding short-term risk, NUTX is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
NUTX vs OSH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas OSH's P/E ratio is -17.65. In terms of profitability, NUTX's ROE is +0.31%, compared to OSH's ROE of +4.64%. Regarding short-term risk, NUTX is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
NUTX vs PACS Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while PACS trades at $46.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas PACS's P/E ratio is 39.80. In terms of profitability, NUTX's ROE is +0.31%, compared to PACS's ROE of +0.27%. Regarding short-term risk, NUTX is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
NUTX vs CHE Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while CHE trades at $511.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas CHE's P/E ratio is 23.66. In terms of profitability, NUTX's ROE is +0.31%, compared to CHE's ROE of +0.25%. Regarding short-term risk, NUTX is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
NUTX vs LHCG Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas LHCG's P/E ratio is 82.83. In terms of profitability, NUTX's ROE is +0.31%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, NUTX is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
NUTX vs LFST Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while LFST trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas LFST's P/E ratio is 173.65. In terms of profitability, NUTX's ROE is +0.31%, compared to LFST's ROE of +0.02%. Regarding short-term risk, NUTX is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
NUTX vs CON Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, CON has a market cap of 4B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while CON trades at $31.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas CON's P/E ratio is 21.95. In terms of profitability, NUTX's ROE is +0.31%, compared to CON's ROE of +0.46%. Regarding short-term risk, NUTX is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CON's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
NUTX vs BKD Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, BKD has a market cap of 3.6B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while BKD trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas BKD's P/E ratio is -26.11. In terms of profitability, NUTX's ROE is +0.31%, compared to BKD's ROE of +401.19%. Regarding short-term risk, NUTX is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check BKD's competition here
National HealthCare Corporation (AMEX: NHC)
NUTX vs NHC Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while NHC trades at $225.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas NHC's P/E ratio is 32.32. In terms of profitability, NUTX's ROE is +0.31%, compared to NHC's ROE of +0.12%. Regarding short-term risk, NUTX is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
NUTX vs OPCH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, OPCH has a market cap of 3.4B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while OPCH trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas OPCH's P/E ratio is 12.59. In terms of profitability, NUTX's ROE is +0.31%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, NUTX is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
NUTX vs AMED Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AMED's P/E ratio is 39.30. In terms of profitability, NUTX's ROE is +0.31%, compared to AMED's ROE of +0.11%. Regarding short-term risk, NUTX is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
NUTX vs ACHC Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, ACHC has a market cap of 3.2B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while ACHC trades at $34.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas ACHC's P/E ratio is 17.34. In terms of profitability, NUTX's ROE is +0.31%, compared to ACHC's ROE of -0.44%. Regarding short-term risk, NUTX is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ACHC's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
NUTX vs MD Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while MD trades at $26.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas MD's P/E ratio is 12.27. In terms of profitability, NUTX's ROE is +0.31%, compared to MD's ROE of +0.20%. Regarding short-term risk, NUTX is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
NUTX vs ADUS Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while ADUS trades at $114.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas ADUS's P/E ratio is 17.79. In terms of profitability, NUTX's ROE is +0.31%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, NUTX is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ADUS's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
NUTX vs AVAH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AVAH trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AVAH's P/E ratio is 13.90. In terms of profitability, NUTX's ROE is +0.31%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, NUTX is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AVAH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
NUTX vs SGRY Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, SGRY has a market cap of 2.1B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while SGRY trades at $15.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas SGRY's P/E ratio is 40.33. In terms of profitability, NUTX's ROE is +0.31%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, NUTX is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SGRY's competition here
Select Medical Holdings Corporation (NYSE: SEM)
NUTX vs SEM Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas SEM's P/E ratio is 15.43. In terms of profitability, NUTX's ROE is +0.31%, compared to SEM's ROE of +0.08%. Regarding short-term risk, NUTX is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
NUTX vs ASTH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while ASTH trades at $40.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas ASTH's P/E ratio is 27.24. In terms of profitability, NUTX's ROE is +0.31%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, NUTX is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
NUTX vs AMEH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AMEH's P/E ratio is 39.25. In terms of profitability, NUTX's ROE is +0.31%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, NUTX is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
NUTX vs AGL Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AGL trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AGL's P/E ratio is -9.57. In terms of profitability, NUTX's ROE is +0.31%, compared to AGL's ROE of -1.46%. Regarding short-term risk, NUTX is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
NUTX vs INNV Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while INNV trades at $11.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas INNV's P/E ratio is -128.44. In terms of profitability, NUTX's ROE is +0.31%, compared to INNV's ROE of -0.09%. Regarding short-term risk, NUTX is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check INNV's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
NUTX vs HCSG Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while HCSG trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas HCSG's P/E ratio is 18.19. In terms of profitability, NUTX's ROE is +0.31%, compared to HCSG's ROE of +0.23%. Regarding short-term risk, NUTX is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check HCSG's competition here
Ardent Health Inc. (NYSE: ARDT)
NUTX vs ARDT Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while ARDT trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas ARDT's P/E ratio is 6.47. In terms of profitability, NUTX's ROE is +0.31%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, NUTX is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check ARDT's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
NUTX vs PNTG Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while PNTG trades at $41.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas PNTG's P/E ratio is 33.46. In terms of profitability, NUTX's ROE is +0.31%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, NUTX is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
NUTX vs AMN Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AMN trades at $32.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AMN's P/E ratio is 10.93. In terms of profitability, NUTX's ROE is +0.31%, compared to AMN's ROE of -0.05%. Regarding short-term risk, NUTX is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
NUTX vs BKDT Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas BKDT's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, NUTX is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
NUTX vs USPH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, USPH has a market cap of 1.1B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while USPH trades at $74.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas USPH's P/E ratio is 28.74. In terms of profitability, NUTX's ROE is +0.31%, compared to USPH's ROE of +0.00%. Regarding short-term risk, NUTX is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check USPH's competition here
COMPASS Pathways plc (NASDAQ: CMPS)
NUTX vs CMPS Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, CMPS has a market cap of 1.1B. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while CMPS trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas CMPS's P/E ratio is -5.49. In terms of profitability, NUTX's ROE is +0.31%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, NUTX is more volatile compared to CMPS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CMPS's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
NUTX vs FSHCX Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, FSHCX has a market cap of 882M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while FSHCX trades at $120.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas FSHCX's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to FSHCX's ROE of N/A. Regarding short-term risk, NUTX is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FSHCX's competition here
Talkspace, Inc. (NASDAQ: TALKW)
NUTX vs TALKW Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, TALKW has a market cap of 874.4M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas TALKW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, NUTX is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check TALKW's competition here
Talkspace, Inc. (NASDAQ: TALK)
NUTX vs TALK Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, TALK has a market cap of 872.7M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while TALK trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas TALK's P/E ratio is 768.44. In terms of profitability, NUTX's ROE is +0.31%, compared to TALK's ROE of +0.01%. Regarding short-term risk, NUTX is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TALK's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
NUTX vs SNDA Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, SNDA has a market cap of 833.8M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while SNDA trades at $41.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas SNDA's P/E ratio is -7.72. In terms of profitability, NUTX's ROE is +0.31%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, NUTX is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SNDA's competition here
Enhabit, Inc. (NYSE: EHAB)
NUTX vs EHAB Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas EHAB's P/E ratio is -197.14. In terms of profitability, NUTX's ROE is +0.31%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, NUTX is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
NUTX vs GMRS Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, GMRS has a market cap of 594M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while GMRS trades at $12.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas GMRS's P/E ratio is 5.76. In terms of profitability, NUTX's ROE is +0.31%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, NUTX is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
NUTX vs TOI Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, TOI has a market cap of 497.9M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while TOI trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas TOI's P/E ratio is -13.83. In terms of profitability, NUTX's ROE is +0.31%, compared to TOI's ROE of +3.27%. Regarding short-term risk, NUTX is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TOI's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
NUTX vs VMD Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, VMD has a market cap of 451.2M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while VMD trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas VMD's P/E ratio is 31.81. In terms of profitability, NUTX's ROE is +0.31%, compared to VMD's ROE of +0.11%. Regarding short-term risk, NUTX is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check VMD's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
NUTX vs MCTA Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas MCTA's P/E ratio is 419.36. In terms of profitability, NUTX's ROE is +0.31%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, NUTX is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
NUTX vs SRTA Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, SRTA has a market cap of 436.1M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while SRTA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas SRTA's P/E ratio is -35.46. In terms of profitability, NUTX's ROE is +0.31%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, NUTX is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SRTA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
NUTX vs TOIIW Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, TOIIW has a market cap of 388.9M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, NUTX's ROE is +0.31%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, NUTX is less volatile compared to TOIIW. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check TOIIW's competition here
Community Health Systems, Inc. (NYSE: CYH)
NUTX vs CYH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, CYH has a market cap of 384M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while CYH trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas CYH's P/E ratio is 3.73. In terms of profitability, NUTX's ROE is +0.31%, compared to CYH's ROE of +0.21%. Regarding short-term risk, NUTX is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
NUTX vs AUNA Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AUNA has a market cap of 373.8M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AUNA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AUNA's P/E ratio is 4.55. In terms of profitability, NUTX's ROE is +0.31%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, NUTX is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AUNA's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
NUTX vs AIRS Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AIRS has a market cap of 325.2M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AIRS trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AIRS's P/E ratio is -153.67. In terms of profitability, NUTX's ROE is +0.31%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, NUTX is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
NUTX vs CSU Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas CSU's P/E ratio is 0.67. In terms of profitability, NUTX's ROE is +0.31%, compared to CSU's ROE of -0.51%. Regarding short-term risk, NUTX is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
NUTX vs JYNT Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, JYNT has a market cap of 119M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while JYNT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas JYNT's P/E ratio is 83.50. In terms of profitability, NUTX's ROE is +0.31%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, NUTX is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check JYNT's competition here
biote Corp. (NASDAQ: BTMD)
NUTX vs BTMD Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, BTMD has a market cap of 100.6M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while BTMD trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas BTMD's P/E ratio is 5.18. In terms of profitability, NUTX's ROE is +0.31%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, NUTX is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check BTMD's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
NUTX vs FVE Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas FVE's P/E ratio is -5.64. In terms of profitability, NUTX's ROE is +0.31%, compared to FVE's ROE of -0.15%. Regarding short-term risk, NUTX is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
NUTX vs KDLYW Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas KDLYW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, NUTX is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check KDLYW's competition here
DocGo Inc. (NASDAQ: DCGO)
NUTX vs DCGO Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, DCGO has a market cap of 58.9M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while DCGO trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas DCGO's P/E ratio is -0.68. In terms of profitability, NUTX's ROE is +0.31%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, NUTX is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
NUTX vs ALR Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas ALR's P/E ratio is -1.11. In terms of profitability, NUTX's ROE is +0.31%, compared to ALR's ROE of -0.15%. Regarding short-term risk, NUTX is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ALR's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
NUTX vs PARK Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, PARK has a market cap of 36.5M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while PARK trades at $18.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas PARK's P/E ratio is 25.36. In terms of profitability, NUTX's ROE is +0.31%, compared to PARK's ROE of -0.24%. Regarding short-term risk, NUTX is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check PARK's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
NUTX vs IMAC Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas IMAC's P/E ratio is -2.27. In terms of profitability, NUTX's ROE is +0.31%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, NUTX is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
NUTX vs PIII Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, PIII has a market cap of 31.5M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while PIII trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas PIII's P/E ratio is -0.24. In terms of profitability, NUTX's ROE is +0.31%, compared to PIII's ROE of +1.85%. Regarding short-term risk, NUTX is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check PIII's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
NUTX vs CCEL Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, CCEL has a market cap of 28.1M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while CCEL trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas CCEL's P/E ratio is -10.55. In terms of profitability, NUTX's ROE is +0.31%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, NUTX is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CCEL's competition here
Cano Health, Inc. (NYSE: CANO-WT)
NUTX vs CANO-WT Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, NUTX is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
NUTX vs AIH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AIH's P/E ratio is -2.78. In terms of profitability, NUTX's ROE is +0.31%, compared to AIH's ROE of +1.16%. Regarding short-term risk, NUTX is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
NUTX vs CANO Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas CANO's P/E ratio is -0.01. In terms of profitability, NUTX's ROE is +0.31%, compared to CANO's ROE of -1.49%. Regarding short-term risk, NUTX is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
NUTX vs FPCG Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas FPCG's P/E ratio is 0.09. In terms of profitability, NUTX's ROE is +0.31%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, NUTX is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
NUTX vs FTRP Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas FTRP's P/E ratio is -1.22. In terms of profitability, NUTX's ROE is +0.31%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, NUTX is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
NUTX vs AMS Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AMS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AMS's P/E ratio is -6.47. In terms of profitability, NUTX's ROE is +0.31%, compared to AMS's ROE of -0.06%. Regarding short-term risk, NUTX is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
NUTX vs BMGL Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, BMGL has a market cap of 9.2M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while BMGL trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas BMGL's P/E ratio is -1.11. In terms of profitability, NUTX's ROE is +0.31%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, NUTX is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
NUTX vs XWEL Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, XWEL has a market cap of 6.4M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while XWEL trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas XWEL's P/E ratio is -0.32. In terms of profitability, NUTX's ROE is +0.31%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, NUTX is more volatile compared to XWEL. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
NUTX vs MODV Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas MODV's P/E ratio is -0.06. In terms of profitability, NUTX's ROE is +0.31%, compared to MODV's ROE of +1.36%. Regarding short-term risk, NUTX is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
NUTX vs GBNH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas GBNH's P/E ratio is -0.06. In terms of profitability, NUTX's ROE is +0.31%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, NUTX is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
NUTX vs RHE Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas RHE's P/E ratio is -1.79. In terms of profitability, NUTX's ROE is +0.31%, compared to RHE's ROE of -0.36%. Regarding short-term risk, NUTX is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
NUTX vs RHE-PA Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, NUTX's ROE is +0.31%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, NUTX is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check RHE-PA's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
NUTX vs AIDX Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AIDX has a market cap of 2.8M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AIDX trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AIDX's P/E ratio is -0.93. In terms of profitability, NUTX's ROE is +0.31%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, NUTX is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
NUTX vs IMACW Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas IMACW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, NUTX is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
NUTX vs NAKAW Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, NUTX's ROE is +0.31%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, NUTX is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
NUTX vs CCM Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, CCM has a market cap of 626.1K. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while CCM trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas CCM's P/E ratio is -0.29. In terms of profitability, NUTX's ROE is +0.31%, compared to CCM's ROE of +0.06%. Regarding short-term risk, NUTX is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
NUTX vs NIVF Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, NIVF has a market cap of 212.3K. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while NIVF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas NIVF's P/E ratio is 0.55. In terms of profitability, NUTX's ROE is +0.31%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, NUTX is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
NUTX vs MNDR Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, MNDR has a market cap of 53.6K. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while MNDR trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas MNDR's P/E ratio is -0.05. In terms of profitability, NUTX's ROE is +0.31%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, NUTX is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
NUTX vs NIVFW Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, NIVFW has a market cap of 50K. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, NUTX's ROE is +0.31%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, NUTX is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check NIVFW's competition here
Hanger, Inc. (NYSE: HNGR)
NUTX vs HNGR Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas HNGR's P/E ratio is 19.71. In terms of profitability, NUTX's ROE is +0.31%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, NUTX is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check HNGR's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
NUTX vs SLHGP Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, NUTX's ROE is +0.31%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, NUTX is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
NUTX vs SLHG Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas SLHG's P/E ratio is -1.48. In terms of profitability, NUTX's ROE is +0.31%, compared to SLHG's ROE of N/A. Regarding short-term risk, NUTX is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
NUTX vs AFAM Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas AFAM's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, NUTX is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
NUTX vs TLMD Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas TLMD's P/E ratio is -1.60. In terms of profitability, NUTX's ROE is +0.31%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, NUTX is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TLMD's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
NUTX vs ATIP-WT Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, NUTX is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check ATIP-WT's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
NUTX vs TVTY Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas TVTY's P/E ratio is 19.06. In terms of profitability, NUTX's ROE is +0.31%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, NUTX is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TVTY's competition here
New Frontier Health Corporation (NYSE: NFH)
NUTX vs NFH Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, NFH has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas NFH's P/E ratio is -19.75. In terms of profitability, NUTX's ROE is +0.31%, compared to NFH's ROE of -0.06%. Regarding short-term risk, NUTX is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check NFH's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
NUTX vs TLMDW Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas TLMDW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, NUTX is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TLMDW's competition here
DocGo Inc. (NASDAQ: DCGOW)
NUTX vs DCGOW Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas DCGOW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.31%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, NUTX is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check DCGOW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
NUTX vs DVCR Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas DVCR's P/E ratio is 28.34. In terms of profitability, NUTX's ROE is +0.31%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, NUTX is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check DVCR's competition here
Kindred Healthcare, Inc. (NYSE: KND)
NUTX vs KND Comparison July 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 868.6M. In comparison, KND has a market cap of 0. Regarding current trading prices, NUTX is priced at $145.87 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 11.27, whereas KND's P/E ratio is -1.14. In terms of profitability, NUTX's ROE is +0.31%, compared to KND's ROE of -0.53%. Regarding short-term risk, NUTX is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check KND's competition here